Organization | San Diego State University

San Diego State University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3

Founded: San Diego CA United States (1897)

Organization Overview

First Clinical Trial

2003

NCT00066950

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

San Diego State University | San Diego State University School of Public Health

Active Ingredients

Drugs in Phase 3 Trials (2)

chlorhexidine (hibitane) (1 trial)

sodium fluoride (18F) (1 trial)

Drugs in Phase 2 Trials (1)

choline (1 trial)

Drugs in Phase 1 Trials (1)

naltrexone (revia) (1 trial)

Drugs in Other Trials (12)

almond (2 trials)

apple (1 trial)

blueberry (1 trial)

calcium (1 trial)

lidocaine (xylocaine) (1 trial)

mango (2 trials)

pistachios (1 trial)

prune (2 trials)

prunus domestica (2 trials)

strawberry (1 trial)

vitamin d3 (1 trial)

watermelon (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Dental Caries (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 19
# of Trial APIs: 16